TITLE:
A 14-Day Study of Racivir When Used in Combination in HIV-Infected Males

CONDITION:
HIV Infections

INTERVENTION:
Racivir

SUMMARY:

      The purpose of this study is to evaluate Racivir. The safety, most effective dosage, and how
      the body reacts to Racivir will be studied.
    

DETAILED DESCRIPTION:

      The study is a 14-day study with a 21-day follow-up period. During the 14-days of active
      study period, participants will receive Racivir once daily in combination with efavirenz and
      stavudine. Following the administration of the first and last dose of study medication,
      patients will remain in the clinic overnight. During the study there will be medical and
      medication histories taken, physical examinations, vital sign measurements, EKGs, and
      routine clinical laboratory tests.
    

ELIGIBILITY:
Gender: Male
Age: 18 Years to 45 Years
Criteria:

        Inclusion Criteria

        Subjects may be eligible to participate if they:

          -  Are males with HIV infection with a positive HIV antibody test

          -  Have an HIV-RNA copy number of  5000 copies/ml (Roche assay)

          -  Have CD4+ cell counts  50 cells/ml

          -  Are 18-45 years of age, inclusive

          -  Have a body mass index (BMI)  18 kg/m2

          -  Are antiretroviral nucleoside reverse transcriptase inhibitor-naive

          -  Have read and understand the informed consent,and is able and willing to comply with
             study procedures

        Exclusion Criteria

        Subjects may not participate if they:

          -  Have clinically significant ECG abnormalities

          -  Have clinically significant abnormalities in any safety laboratory parameters

          -  Have an ALT value  3xUNL

          -  Have previously participated in this trial

          -  Have participated in another trial of an investigational drug within the last 3
             months or are currently participating in another trial of an investigational drug

          -  Have a history of chronic alcohol or drug abuse within the last 6 months

          -  Have a positive urine drug screening

          -  Have a positive alcohol breath test

          -  Have any medical or psychiatric condition, which in the opinion of the investigator
             would jeopardize or compromise the subjects ability to participate in this trial

          -  Have a known hypersensitivity to any components of the trial medication or
             comparative drugs as stated in this protocol
      
